Oncogene - Table of Contents alert Volume 31 Issue 20

TABLE OF CONTENTS Volume 31, Issue 20 (May 2012) In this issue Review Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Nature and Nature Reviews Cancer WEB FOCUS: CANCER METABOLISM A renaissance in the field of cancer metabolism has demonstrated links between oncogenic pathways and the mechanistic basis of tumour cell metabolism. This joint Nature and Nature Reviews Cancer Web Focus highlights recent progress in the field and the promise of therapeutics based on interfering with metabolic pathways. Access the Web Focus at: www.nature.com/focus/cancermetabolism   Review Top MicroRNA-mediated breast cancer metastasis: from primary site to distant organs L Wang and J Wang Oncogene 2012 31: 2499-2511; advance online publication, October 3, 2011; 10.1038/onc.2011.444 Abstract | Full Text Original Articles Top Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells Y Wang, Q Sheng, M A Spillman, K Behbakht and H Gu Oncogene 2012 31: 2512-2520; advance online publication, September 26, 2011; 10.1038/onc.2011.435 Abstract | Full Text Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer L Cao, M Shao, J Schilder, T Guise, K S Mohammad and D Matei Oncogene 2012 31: 2521-2534; advance online publication, October 3, 2011; 10.1038/onc.2011.429 Abstract | Full Text A KrasG12D-driven genetic mouse model of pancreatic cancer requires glypican-1 for efficient proliferation and angiogenesis C A Whipple, A L Young and M Korc Oncogene 2012 31: 2535-2544; advance online publication, September 26, 2011; 10.1038/onc.2011.430 Abstract | Full Text Heterogeneity in MYC-induced mammary tumors contributes to escape from oncogene dependence J Y Leung, E R Andrechek, R D Cardiff and J R Nevins Oncogene 2012 31: 2545-2554; advance online publication, September 26, 2011; 10.1038/onc.2011.433 Abstract | Full Text Aryl hydrocarbon receptor in association with RelA modulates IL-6 expression in non-smoking lung cancer P-H Chen, H Chang, J T Chang and P Lin Oncogene 2012 31: 2555-2565; advance online publication, September 26, 2011; 10.1038/onc.2011.438 Abstract | Full Text F-box protein FBXL2 exerts human lung tumor suppressor-like activity by ubiquitin-mediated degradation of cyclin D3 resulting in cell cycle arrest B B Chen, J R Glasser, T A Coon and R K Mallampalli Oncogene 2012 31: 2566-2579; advance online publication, October 24, 2011; 10.1038/onc.2011.432 Abstract | Full Text NF-κB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the β-catenin pathway Y M Thu, Y Su, J Yang, R Splittgerber, S Na, A Boyd, C Mosse, C Simons and A Richmond Oncogene 2012 31: 2580-2592; advance online publication, October 3, 2011; 10.1038/onc.2011.427 Abstract | Full Text Short Communication Top Proteins kinase Cε is required for non-small cell lung carcinoma growth and regulates the expression of apoptotic genes M C Caino, C Lopez-Haber, J Kim, D Mochly-Rosen and M G Kazanietz Oncogene 2012 31: 2593-2600; advance online publication, September 26, 2011; 10.1038/onc.2011.428 Abstract | Full Text Advertisement Covering basic research and clinical applications, Cellular & Molecular Immunology (CMI) provides the latest information and advancements in our understanding of the immunological response of the host, both in vitro and in vivo. Make sure you receive the latest research - Register for your CMI Electronic Table of Contents (eToC) alerts today.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.